HRP20131103T1 - Benzimidazoli i njihovi farmaceutski pripravci - Google Patents

Benzimidazoli i njihovi farmaceutski pripravci Download PDF

Info

Publication number
HRP20131103T1
HRP20131103T1 HRP20131103AT HRP20131103T HRP20131103T1 HR P20131103 T1 HRP20131103 T1 HR P20131103T1 HR P20131103A T HRP20131103A T HR P20131103AT HR P20131103 T HRP20131103 T HR P20131103T HR P20131103 T1 HRP20131103 T1 HR P20131103T1
Authority
HR
Croatia
Prior art keywords
image
aryl
cycloalkyl
alkyl
heterocyclic
Prior art date
Application number
HRP20131103AT
Other languages
English (en)
Croatian (hr)
Inventor
Iwao Ojima
Seung-Yub Lee
Original Assignee
The Research Foundation Of State University Of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Research Foundation Of State University Of New York filed Critical The Research Foundation Of State University Of New York
Publication of HRP20131103T1 publication Critical patent/HRP20131103T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HRP20131103AT 2007-04-20 2008-04-21 Benzimidazoli i njihovi farmaceutski pripravci HRP20131103T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91298007P 2007-04-20 2007-04-20
PCT/US2008/005084 WO2008130669A1 (en) 2007-04-20 2008-04-21 Benzimidazoles and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
HRP20131103T1 true HRP20131103T1 (hr) 2013-12-20

Family

ID=39875833

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20131103AT HRP20131103T1 (hr) 2007-04-20 2008-04-21 Benzimidazoli i njihovi farmaceutski pripravci

Country Status (17)

Country Link
US (1) US8232410B2 (enExample)
EP (1) EP2154966B1 (enExample)
JP (1) JP5400032B2 (enExample)
CN (1) CN101677553A (enExample)
AU (1) AU2008242488B2 (enExample)
BR (1) BRPI0810244A2 (enExample)
CA (1) CA2684594C (enExample)
DK (1) DK2154966T3 (enExample)
EA (1) EA016726B1 (enExample)
ES (1) ES2434693T3 (enExample)
HR (1) HRP20131103T1 (enExample)
IN (1) IN2009KN03959A (enExample)
MX (1) MX2009011281A (enExample)
PL (1) PL2154966T3 (enExample)
PT (1) PT2154966E (enExample)
SI (1) SI2154966T1 (enExample)
WO (1) WO2008130669A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8232310B2 (en) 2006-12-29 2012-07-31 Georgetown University Targeting of EWS-FLI1 as anti-tumor therapy
US8039502B2 (en) 2007-07-24 2011-10-18 The Ohio State University Research Foundation Anti-infective agents against intracellular pathogens
US20120108823A1 (en) 2009-04-22 2012-05-03 The Ohio State University Research Foundation Anti-francisella agents
PL2475428T3 (pl) 2009-09-11 2015-12-31 Probiodrug Ag Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
WO2013116823A1 (en) * 2012-02-02 2013-08-08 The Research Foundation Of State University Of New York Benzimidazoles and uses thereof
WO2013142326A1 (en) * 2012-03-23 2013-09-26 The Research Foundation Of State University Of New York 5-carbonylamino-/(sulfonamido-) substituted benz imidazoles and use thereof treatment of tuberculosis
NZ700612A (en) * 2012-04-12 2016-09-30 Univ Georgetown Methods and compositions for treating ewings sarcoma family of tumors
CN103333170B (zh) * 2013-06-14 2016-08-10 清华大学 苯并咪唑类化合物及其用途
US9511050B2 (en) 2013-10-24 2016-12-06 Georgetown University Methods and compositions for treating cancer
CN106061951A (zh) * 2013-11-22 2016-10-26 纽约州立大学研究基金会 苯并咪唑及其在结核病治疗中的用途
US10287617B2 (en) 2014-03-11 2019-05-14 Colorado State University Research Foundation Methods for in vitro—in vivo efficacy determination
US11279714B2 (en) * 2014-06-20 2022-03-22 Institut Pasteur Korea Anti-infective compounds
CN111777596A (zh) 2014-10-09 2020-10-16 英克特诺治疗公司 吲哚酮化合物及其用途
WO2017172368A1 (en) 2016-03-31 2017-10-05 Oncternal Therapeutics, Inc. Indoline analogs and uses thereof
CN109789127B (zh) 2016-07-29 2022-03-25 英克特诺治疗公司 吲哚啉酮化合物的用途
CN111303092B (zh) * 2020-04-07 2021-05-25 山东昌邑灶户盐化有限公司 2,4-二硝基-6-氯苯胺衍生物、合成方法及其应用
TW202317546A (zh) 2021-07-09 2023-05-01 美商普萊克斯姆公司 調節ikzf2之芳基化合物及醫藥組合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61170732A (ja) * 1985-01-25 1986-08-01 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US7405235B2 (en) * 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
CA2582356A1 (en) * 2004-09-30 2006-04-13 Janssen Pharmaceutica N.V. Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
EP2008210A1 (en) 2006-03-15 2008-12-31 Csir Modulation of phosphoryl transferase activity of glutamine synthetase

Also Published As

Publication number Publication date
PL2154966T3 (pl) 2014-03-31
SI2154966T1 (sl) 2014-02-28
EP2154966B1 (en) 2013-08-21
US8232410B2 (en) 2012-07-31
EP2154966A1 (en) 2010-02-24
PT2154966E (pt) 2013-11-13
IN2009KN03959A (enExample) 2015-08-28
CA2684594A1 (en) 2008-10-30
WO2008130669A1 (en) 2008-10-30
AU2008242488A1 (en) 2008-10-30
CN101677553A (zh) 2010-03-24
DK2154966T3 (da) 2013-11-18
MX2009011281A (es) 2010-03-08
ES2434693T3 (es) 2013-12-17
EA200901423A1 (ru) 2010-06-30
EP2154966A4 (en) 2010-12-15
JP2010524947A (ja) 2010-07-22
AU2008242488B2 (en) 2014-10-30
US20100256203A1 (en) 2010-10-07
EA016726B1 (ru) 2012-07-30
BRPI0810244A2 (pt) 2014-09-30
CA2684594C (en) 2015-10-06
JP5400032B2 (ja) 2014-01-29

Similar Documents

Publication Publication Date Title
HRP20171740T1 (hr) Derivati 5-((halofenil)-3-hidroksi-piridin-2-yl-karboksilne kiseline kao posrednici za pripravu karbonilamino alkanoinskih kiselina, njihovih estera i amida
AR052458A1 (es) Amino-imidazolonas para la inhibicion de beta-secretasa
AR059622A1 (es) Quinolonas utiles como inhibidores de la sintetasa del oxido nitrico inducibles
AR063988A1 (es) Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
HRP20200561T1 (hr) Prolijekovi spoja jak inhibitora za liječenje gastrointestinalnih upalnih bolesti
HRP20130846T1 (hr) Derivati indolizina i njihova uporaba u medicinske svrhe
HRP20080549T3 (en) 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
HRP20161103T1 (hr) Kemijski spojevi
HRP20090250T1 (hr) Kondenzirani heterociklički spojevi i njihova upotreba kao inhibitora hcv polimeraze
HRP20080186T3 (en) Use of tricyclic compounds as glycine transport inhibitors
AR010378A1 (es) Novedosos compuestos con efecto analgesico, uso de los mismos para la preparacion de un medicamento y como agente de diagnostico, composicion farmaceutica, proceso para la preparacion de dichos compuestos y compuestos intermediarios
ATE370145T1 (de) Tricyclische verbindungen auf thiophengrundlage und pharmazeutische zusammensetzungen, die diese enthalten
ATE513546T1 (de) Imidazolidin-derivate, ihre verwendungen, ihre zubereitung und diese enthaltende zusammensetzungen
AR067008A1 (es) Derivados 3- amino-6-(1- amino - etil)-tetrahidropirano
AR049401A1 (es) Aza-biciclononanos
MX344276B (es) Compuesto de piperidina novedoso o sal del mismo.
JP2010524947A5 (enExample)
RU2005105592A (ru) Макролидные соединения, обладающие противовоспалительной активностью
CA2873096A1 (en) Compositions and methods for the treatment of inflammatory bowel disease
HRP20070498T3 (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
HRP20160465T1 (hr) Novi supstituirani derivati izokinolina
AR069800A1 (es) Derivados 5- aminociclilmetil - oxazolidin-2- ona
MX2009002685A (es) Derivados de acetamida de (2- (1-oxo-1h-isoquinolin-2-il).
AR072103A1 (es) Derivados de (piperazinilo con enlaces puente)-1- alcanona, su utilizacion como inhibidores de p75 y composiciones farmaceuticas que los contienen
JP2006517932A5 (enExample)